Gilead Sciences

Gilead Sciences, Inc. is a renowned biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. Since its foundation in 1987, it has become one of the world's largest pharmaceutical companies. It is dedicated to transforming and simplifying care for people with life-threatening illnesses around the world. The company's broad-spectrum portfolio of treatments includes antiviral drugs for diseases such as HIV/AIDS, Hepatitis B and C, and influenza, among others. Furthermore, Gilead Sciences is known for its research and development efforts in potential treatments for diseases like oncology, hematology, inflammation, and respiratory disease.
Gilead Sciences' pursuit of novel science, harnessing intellectual rigor to bring forward medicines that have the potential to redefine standards of care in areas of high medical need, sets it apart. The company's commitment to patient access to its products is evident in its various access initiatives and patient support programs. Indeed, Gilead Sciences' corporate description emphasizes its dedication to creating a healthier world through innovative healthcare solutions.